PMV Pharmaceuticals, Inc. Earnings Per Share, Basic in USD/shares from 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
PMV Pharmaceuticals, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2020 to Q3 2025.
  • PMV Pharmaceuticals, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2025 was -0.4 USD/shares, a 8.11% decline year-over-year.
  • PMV Pharmaceuticals, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2025 was -1 USD/shares, a 61.6% decline year-over-year.
  • PMV Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2024 was -1.14 USD/shares, a 20.8% increase from 2023.
  • PMV Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2023 was -1.44 USD/shares, a 10.6% increase from 2022.
  • PMV Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2022 was -1.61 USD/shares, a 25.8% decline from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)

PMV Pharmaceuticals, Inc. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$1 $0 $0 -8.11% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-12
Q2 2025 -$1 $0 $0 -1950% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-07
Q1 2025 -$1 $0 $0 -13.3% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-09
Q4 2024 -$1 $0 $0 -50% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-03
Q3 2024 $0 $0 $0 -8.82% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-12
Q2 2024 $0 $0 +$0.36 +94.7% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-07
Q1 2024 -$1 $0 +$0.12 +28.6% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-09
Q4 2023 -$1 $0 +$0.12 +28.6% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-03
Q3 2023 -$1 $0 +$0.06 +15% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$1 $0 $0 0% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$1 $0 $0 -2.44% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$1 $0 Oct 1, 2022 Dec 31, 2022 10-K 2025-03-03
Q3 2022 $0 $0 -21.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $0 Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q3 2021 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08

PMV Pharmaceuticals, Inc. Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$1 +$0.30 +20.8% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-03
2023 -$1 +$0.17 +10.6% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-03
2022 -$2 $0 -25.8% Jan 1, 2022 Dec 31, 2022 10-K 2025-03-03
2021 -$1 +$1.12 +46.7% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 -$2 Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.